
Oscor Impella Introducer Kit
Oscor recalls Abiomed Impella Introducer Kit (14F) due to sheath leakage risk.
Stop using the affected introducer kit immediately. Contact Oscor Inc. for instructions on returning the product and obtaining a replacement. If you have used this device on a patient, monitor for any signs of leakage or complications and report any adverse events to the FDA.
Why it was recalled
Oscor Inc. is recalling the Abiomed Introducer Kit for the Impella Hemostatic Peel Away Introducer System with Infusion Sideport, 14F 13cm and 25cm, due to a manufacturing issue that may cause the introducer sheaths to leak from the sidearm, under the sheath cap, and along the hub score lines. Leakage could compromise device performance and patient safety.
Is mine affected?
Check the model, lot, or serial number on the device or its packaging. Yours is affected if it matches one below.
| Product | Lot code | Recall # | UDI-DI |
|---|---|---|---|
| Abiomed REF: 0052-3025, Introducer Kit for Impella Hemostatic Peel Away Introducer System with Infusion Sideport, 14F 13cm and 25cm. heart pump and accessories. | All Lots within Expiry/GTIN:00885672009793, 00813502010664 | Z-2678-2026 | 00885672009793, 00813502010664 |
| Abiomed REF: 0052-3021, Introducer Kit for Impella Hemostatic Peel Away Introducer System with Infusion Sideport, 14F, 23F. heart pump and accessories. | All Lots within Expiry/GTIN:00885672009786/00813502010558 | Z-2679-2026 | 00885672009786, 00813502010558 |
| Abiomed REF: 0052-3006, Introducer Kit for Impella Hemostatic Peel Away Introducer System with Infusion Sideport, 23F. heart pump and accessories. | All Lots within Expiry/GTIN:00885672009755/00813502011609 | Z-2680-2026 | 00885672009755, 00813502011609 |
Where it was sold
Distributed in Massachusetts.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Manufacturing Deviation recalls
Editorial summary by Recall Canary · summary updated 2026-09-03 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification
